Abstract
In the last decades, 18F-FDG PET imaging has been extensively used to study glucose brain metabolism [1]. Glucose uptake distribution in the brain is mainly driven by basal neuronal activity and represents general neuronal integrity [2, 3]. The highest values of glucose consumption are found in the basal ganglia, the thalami, and the occipital polar and mesial cortex, while the medial temporal cortex and the cerebellum have the lowest values. Physiologic glucose demand is very high in brain tissue in normal condition [3]. Due to the high physiological uptake in normal brain gray matter and variable uptake by inflammatory lesions it has thus a limited role in oncology. It can be used in selected cases to distinguish tumor recurrence from radiation necrosis in enhancing brain lesions or to distinguish gliomas from CNS lymphoma or opportunistic infections [4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Germany, part of Springer Nature
About this chapter
Cite this chapter
Fanti, S., Farsad, M., Mansi, L., Castellucci, P. (2018). Brain 18F-Fluorodeoxyglucose (FDG) PET. In: Atlas of PET-CT. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57742-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-57742-4_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57740-0
Online ISBN: 978-3-662-57742-4
eBook Packages: MedicineMedicine (R0)